REFILE-UPDATE 2-FDA knocks back Achaogen's drug for bloodstream infection
June 26, 2018 at 12:43 PM EDT
June 26 (Reuters) - The U.S. Food and Drug Administration cleared Achaogen Inc's antibiotic to treat adults with complicated urinary tract infections, but shares slumped 25 percent as the drug failed to win approval for treating bloodstream infections.